Coronavirus & Atopic Dermatitis Reporting Registry
101801018010180
EPI Health has graciously supported the COVID-19 News and Resource Center.
SECURE-AD (Surveillance Epidemiology of Corona Virus (COVID-19) Under Research Exclusion - Atopic Dermatitis) is a secure, online, de-identified international reporting registry for health care providers to report outcomes of COVID-19 in atopic dermatitis (AD) patients.
Clinicians worldwide are encouraged to report al …
EPI Health has graciously supported the COVID-19 News and Resource Center.
SECURE-AD (Surveillance Epidemiology of Corona Virus (COVID-19) Under Research Exclusion - Atopic Dermatitis) is a secure, online, de-identified international reporting registry for health care providers to report outcomes of COVID-19 in atopic dermatitis (AD) patients.
Clinicians worldwide are encouraged to report al … Continue reading "Coronavirus & Atopic Dermatitis Reporting Registry"
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference interviewed Dr. Adam Friedman, Professor, Interim Chair of Dermatology, and Residency Program Director at George Washington University, on some of the common misconceptions and controversies surrounding photoprotection.
With ample evidence today that shows that sunscreen both reduces the incidence of me … 
EPI Health has graciously supported the COVID-19 News and Resource Center.
USA TODAY and countless other media outlets have recently covered a dermatological phenomenon called COVID toes. Are COVID toes a true skin manifestation of COVID-19?
For an expert opinion, I consulted dermatologist Amy McMichael, MD, professor and chair of the department of dermatology, Wake Forest Baptist Medical Ce … 
Have you ever come across a patient with a skin cancer that you are not 100% sure should be treated with Mohs surgery or an alternative modality? Or a patient who comes back for a follow-up after skin cancer surgery with an undesirable scar and you wonder if you should have opted for a less invasive option? I certainly have. Some of these nagging questions were answered by a thoughtful, case-based … 
JDD Authors Rachel Fayne BA, Sonali Nanda MS, Anna Nichols MD PhD, and John Shen MD report a case of biopsy-proven invasive SCC in an 86-year-old Caucasian male with history of multiple actinic keratoses and no previous skin cancers. The patient declined surgical treatment due to concerns about cosmetic outcomes. A combination of topical 5% imiquimod cream, 2% 5-FU solution, and 0.1% tretinoin cre … 